DOCSLIB.ORG

Risk Groups: Viruses (C) 1988, American Biological Safety Association

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Risk Groups: Viruses (C) 1988, American Biological Safety Association Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/ Animal virus 26 1 2 + virus vector 1 Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Bovine spongiform Unconventional agents, 27 2 3 + encephalopathy prions 28 Buenaventura X-Arboviruses Buffalopox virus: 2 29 viruses(1 a vaccinia Poxviridae 2 implied 2 2 implied 2 2 + + variant) Bunyaviridae/ Bunyavirus 30 Bunyamwera virus 2 2 2 2 2 + + Group Bunyaviridae/ Bunyavirus 31 Bunyavirus 2 Group 32 Cabassou X-Arboviruses 2 see arbovirus 33 Cache valley X-Arboviruses table 2 (incl California Bunyaviridae/ Bunyavirus 2 see arbovirus 3 human, 2 34 2 LaCrosse, 2 + + encephalitis virus Group table animal Lumbo and 35 Camel pox virus Poxviridae 2 implied 2 2 implied 3 + 2 36 Cardiovirus Picornaviridae 2 all isolates Encephalomyoc + arditis Group Central European Flaviviridae/ Flavivirus (Grp 37 Tick-borne 4 4 3 V (**) B Arbovirus) encephalitis Chick embryo lethal 38 Viral vector/Animal virus orphan CELO 2, high passage Togaviridae/ Alphavirus (Grp 3 arbovirus 3 (recent 39 Chikungunya virus strains;vaccine 3 arbovirus table 3 (**) 3 # + A Arbovirus) table isolates) strain131/25 40 Chim X-Arboviruses 41 Cocal X-Arboviruses 2 (including 42 Coltiviruses Reoviridae Colorado Tick 2 2 + + Fever) Congo Crimean 4 (Crimean- 43 haemorrhagic fever Bunyaviridae/ Nairoviruses 4 4 4 4 4 + Congo) TBE 2 (human, 44 Coronavirus Coronaviridae 2 2 2 human + + bovine) 45 Cowpox virus Poxviridae 2 V 2 2 implied 2 2 + + 2 ( Types A and 46 Coxsackie Picornoviridae/ Enterovirus 2 2 2 2 + B) Creutzfeldt-Jacob 47 Unconventional agents/prion 2 3 3 3 (**) D 3 2 C,G + disese 2 Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Cytomegalovirus Herpesviridae/ 2 all isolates 48 (CMV) Genus 2 2 2 2 (HH5) 2 + Betaherpesviridae HHV5 Lymphocryptovirus Flaviviridae/ Flavivirus (Grp 49 Dengue virus Type 1-4 2 2 (types1-4), 3 2,Types 1-4 3, type 1-4 3 2 + B Arbovirus) 50 Dhori X-Arboviruses 3 arbovirus table 3 arbovirus 51 Dog sarcoma Viral vector/Animal virus 52 Dugbe X-Arboviruses Eastern equine Togaviridae/ Alphavirus (Grp 53 encephalomyelitis 2 V 2 V 3 3 V 3 3 + + A Arbovirus) (EEE) 54 Ebola virus Filoviridae 4 4 4 4 4 4 + + 55 Echoviruses Picornoviridae/ Enterovirus 2 2 2 2 2 + Ectromelia 56 Orthopoxvirus (mousepox) Elephantpox virus 57 Poxviridae 2 2 implied 2 2 + + (variant of cowpox) 58 Entero Picornoviridae/ Enterovirus 2 2 2, Epstein-Barr virus Herpesviridae/ 59 2 2 2 implied, HH4 2 2 Lymphocryptovi + (EBV) Gammaherpesviridae rus (EB-like) Togaviridae/ Alphavirus (Grp 3 arbovirus 60 Everglade virus 3 arbovirus table 3 (**) 3 + A Arbovirus) table Feline leukemia 61 Viral vector/Animal retrovirus 1 3 wild strain + virus, FeLV Feline sarcoma virus, 62 Viral vector/Animal retrovirus 1 3 wild strain + FeSV Flanders-Hart Park from mosquitoes 2 arbovirus 63 virus (see Zinsser, pg Rhabdoviridae and birds, no 2 arbovirus table table 777) human sx Herpesviridae / 64 Gammaherpes 3 Gammaherpesvirinae Ganjam (USDA 65 X-Arboviruses permit) 66 Garba X-Arboviruses 3 arbovirus table 3 arbovirus 3 see arbovirus 67 Germiston X-Arboviruses 3 table Gerstmann- Unconventional agents, 68 2 implied 3 implied 3 (**) D(d) 3 2 C,G + Straussler-Scheinker prions 69 Getah X-Arboviruses 3 arbovirus table 3 arbovirus Gibbon leukemia 70 Viral vector/Animal retrovirus 1 virus (GaLV) 71 Gordil X-Arboviruses 3 arbovirus table 3 arbovirus 72 Guanarito Arenaviruses 4 4 4 4 + 3 Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII 73 Guaratuba X-Arboviruses 2 arbovirus table 2 arbovirus 74 Guinea pig herpes Viral vector/Animal virus 1 75 Hamster leukemia Viral vector/Animal virus 1 Hantaan (Korean see also sin 76 Bunyaviridae/ Hantaviruses 3 3 3 3 3 3 + haemorrhagic fever) nombre virus Flaviviridae/ Flavivirus (Grp 77 Hanzalova,TBE 4 4 4 implied 3 3 4 + B Arbovirus) Hart Park virus (see 2 arbovirus 78 Rhabdoviridae 2 arbovirus table Zinsser, pg 777) table 79 Hazara virus Bunyaviridae/ Nairoviruses 2 arbovirus table 2 arbovirus 2 2 4 + Hepatitis A virus, 2 all 80 human enterovirus Picornoviridae/ Hepatovirus 2 V 2 2 V 2 2 + hepatoviruses type 72 2 (includes 81 Hepatitis B virus Hepadnaviridae 2 V 2 3 (**)V,D 3 2,G.V + Delta Togaviridae/ (hepatitis non- 82 Hepatitis C 2 2 2 3(**),D 3 2 (unclassified) + Pestivirus(Canada) A,non-B) Delta, only Hepatitis D (Delta) 83 Hepadnaviridae pathogenic with 2 2 3(**)V, D 2 (unclassified) + virus HBV inf. 84 Hepatitis E virus Calciviridae 2 2 2 3(**) 3 2 + 85 Herpes saimiri Herpesviridae/ Rhadinovirus 3 2 + Herpes simplex Herpesviridae/ 2 (types 1 and 2 (HHV 1 and 2 ( types 1 and 86 Type 1 and 2 (EC) 2 2 2,E + viruses Alphaherpesviridae 2) 2) 2) 87 Herpesvirus ateles Herpesviridae/ Rhadinovirus 1 3 Herpesvirus saimiri, Herpesviridae/ Animal virus 88 1 Genus Rhadinovirus vector Herpesvirus simiae Herpesviridae/ 3 human, 2 89 3/4 4 4 3 4 (B virus) Alphaherpesviridae animal Herpesvirus zoster Herpesviridae/ 90 2 2 2 (VZV,HHV3) 2 2 2,E + (Varicella) Alphaherpesviridae Human B 2 (Herpes types 91 Herpesviridae HHV 6 2 (HBLV-HHV6) 2 + lymphotropic virus 6 and 7) Human Immunodeficiency 1, 2 (AIDS 3 ( Types 1 and 92 Retroviridae/ Lentiviridae 2/2+/3 2 or 3 3 (**)D 3 2 G, E + virus(HIV) Types 1 causing) 2) and 2 Oncornavirus Human T-cell Retroviridae/ Oncovirinae/ Types 1-3 (EC 1 3 (Types 1 and 3 (**)D,types 1 2,G,E Types I 93 lymphotropic viruses 2/3 3 3 + Genus Oncornavirus C and 2) 2) and 2 and II (HTLV) Flaviviridae/ Flavivirus (Grp 94 Hypr,TBE 4 4 4 implied 3 3 4 + B Arbovirus) 95 Ibaraki X-Arboviruses 3 arbovirus table 3 arbovirus 4 Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII vaccine strains: Influenza virus 96 Orthomyxoviridae A/PR8/34, 1 (vaccine strain) A/WS/33 2 human, 3 Influenza virus,Types Types A,B, and C 2,V for Types 2,V recent 97 Orthomyxoviridae 2 2 (types A,B, C) 2 animal (types A, + + A-C (EC) A,B isolates B, C) 98 Inhangapi X-Arboviruses 3 arbovirus table 3 arbovirus 99 Inini X-Arboviruses 3 arbovirus table 3 arbovirus 100 Israel Turkey X-Arboviruses 3 arbovirus table 3 arbovirus 101 Issyk-Kul X-Arboviruses 3 arbovirus table 3 arbovirus 102 Itaituba X-Arboviruses 3 arbovirus table 3 arbovirus Japanese B Flaviviridae/Flavivirus (Grp B 3 arbovirus 103 3 arbovirus table 3 3 V 3 # 3 + encephalitis Arbovirus) table Japanese Flaviviridae/Flavivirus (Grp B 104 encephalitis, 2 + Arbovirus) Nakayama 105 Junin virus Arenaviruses 3V/4 4, 3 (v) 4 4 4 4 + 106 Kairi(x) X-Arboviruses i 3 arbovirus table 3 arbovirus 107 Khasan, Koutango X-Arboviruses 3 arbovirus table 3 arbovirus Flaviviridae/ Flavivirus (Grp 108 Kokobera B Arbovirus) Flaviviridae/ Flavivirus (Grp 109 Kumlinge,TBE I 4 4 4 implied 3 3 + B Arbovirus) Flaviviridae/ Flavivirus (Grp 2 arbovirus 110 Kunjin 2 arbovirus table 2 2 B Arbovirus) table 111 Kuru Unconventional agents/prion 2 3 3 3 (**) D (d) 3 2 C,G + Kyasanur Forest, Flaviviridae/ Flavivirus (Grp 112 4 4 4 3 (**) V 3 4 + + TBE B Arbovirus) 113 Kyzylagach X-Arboviruses 3 arbovirus table 3 arbovirus 114 LaCrosse virus X-Arboviruses 2 arbovirus table 2 arbovirus 115 Langat virus X-Arboviruses 2 arbovirus table 2 arbovirus 116 Lassa fever virus Arenaviruses 4 4 4 4 4 4 + Lentivirinae , except 117 Retroviridae 2 HIV-1 and HI Flaviviridae/ Flavivirus (Grp 3 arbovirus 118 Looping ill , TBE 3 arbovirus table 4 implied 3 (**) 3 + + B Arbovirus) table 119 Lucke (frog) virus Viral vector/Animal virus Lymphocytic 120 choriomeningitis Arenaviruses neurotropic strains 2/3 3 3
Load more

Recommended publications
  • Recognition TLR7 Signaling Beyond Endosomal Dendritic Cells
    Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition This information is current as of September 29, 2021. Jennifer P. Wang, Ping Liu, Eicke Latz, Douglas T. Golenbock, Robert W. Finberg and Daniel H. Libraty J Immunol 2006; 177:7114-7121; ; doi: 10.4049/jimmunol.177.10.7114 http://www.jimmunol.org/content/177/10/7114 Downloaded from References This article cites 38 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/177/10/7114.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition1 Jennifer P. Wang,2* Ping Liu,† Eicke Latz,* Douglas T. Golenbock,* Robert W. Finberg,* and Daniel H.
    [Show full text]
  • The Positive Rhinovirus/Enterovirus Detection and SARS-Cov-2 Persistence Beyond the Acute Infection Phase: an Intra-Household Surveillance Study
    viruses Communication The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study Pedro Brotons 1,2,3, Iolanda Jordan 1,3,4, Quique Bassat 3,5,6,7,8 , Desiree Henares 1,3, Mariona Fernandez de Sevilla 1,3,5, Sara Ajanovic 7, Alba Redin 1,2, Vicky Fumado 1,5, Barbara Baro 7 , Joana Claverol 9, Rosauro Varo 7 , Daniel Cuadras 9 , Jochen Hecht 10, Irene Barrabeig 3,11, Juan Jose Garcia-Garcia 1,3,5, Cristian Launes 1,3,5,† and Carmen Muñoz-Almagro 1,2,3,12,*,† 1 Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain; [email protected] (P.B.); [email protected] (I.J.); [email protected] (D.H.); [email protected] (M.F.d.S.); [email protected] (A.R.); [email protected] (V.F.); [email protected] (J.J.G.-G.); [email protected] (C.L.) 2 Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Sant Cugat, 08195 Barcelona, Spain 3 Consorcio de Investigacion Biomédica en Red Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain; [email protected] (Q.B.); [email protected] (I.B.) 4 Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain 5 Pediatrics Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain 6 Centro de Investigação em Saúde de Manhiça (CISM), Manhiça 1929, Mozambique Citation: Brotons, P.; Jordan, I.; 7 ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain; [email protected] (S.A.); Bassat, Q.; Henares, D.; Fernandez de [email protected] (B.B.); [email protected] (R.V.) Sevilla, M.; Ajanovic, S.; Redin, A.; 8 Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain Fumado, V.; Baro, B.; Claverol, J.; et al.
    [Show full text]
  • MDHHS BOL Mosquito-Borne and Tick-Borne Disease Testing
    MDHHS BUREAU OF LABORATORIES MOSQUITO-BORNE AND TICK-BORNE DISEASE TESTING MOSQUITO-BORNE DISEASES The Michigan Department of Health and Human Services Bureau of Laboratories (MDHHS BOL) offers comprehensive testing on clinical specimens for the following viral mosquito-borne diseases (also known as arboviruses) of concern in Michigan: California Group encephalitis viruses including La Crosse encephalitis virus (LAC) and Jamestown Canyon virus (JCV), Eastern Equine encephalitis virus (EEE), St. Louis encephalitis virus (SLE), and West Nile virus (WNV). Testing is available free of charge through Michigan healthcare providers for their patients. Testing for mosquito-borne viruses should be considered in patients presenting with meningitis, encephalitis, or other acute neurologic illness in which an infectious etiology is suspected during the summer months in Michigan. Methodologies include: • IgM detection for five arboviruses (LAC, JCV, EEE, SLE, WNV) • Molecular detection (PCR) for WNV only • Plaque Reduction Neutralization Test (PRNT) is also available and may be performed on select samples when indicated The preferred sample for arbovirus serology at MDHHS BOL is cerebral spinal fluid (CSF), followed by paired serum samples (acute and convalescent). In cases where CSF volume may be small, it is recommended to also include an acute serum sample. Please see the following document for detailed instructions on specimen requirements, shipping and handling instructions: http://www.michigan.gov/documents/LSGArbovirus_IgM_Antibody_Panel_8347_7.doc Michigan residents may also be exposed to mosquito-borne viruses when traveling domestically or internationally. In recent years, the most common arboviruses impacting travelers include dengue, Zika and chikungunya virus. MDHHS has the capacity to perform PCR for dengue, chikungunya and Zika virus and IgM for dengue and Zika virus to confirm commercial laboratory arbovirus findings or for complicated medical investigations.
    [Show full text]
  • A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses
    A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses. Laurent Dacheux, Minerva Cervantes-Gonzalez, Ghislaine Guigon, Jean-Michel Thiberge, Mathias Vandenbogaert, Corinne Maufrais, Valérie Caro, Hervé Bourhy To cite this version: Laurent Dacheux, Minerva Cervantes-Gonzalez, Ghislaine Guigon, Jean-Michel Thiberge, Mathias Vandenbogaert, et al.. A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses.. PLoS ONE, Public Library of Science, 2014, 9 (1), pp.e87194. 10.1371/journal.pone.0087194.s006. pasteur-01430485 HAL Id: pasteur-01430485 https://hal-pasteur.archives-ouvertes.fr/pasteur-01430485 Submitted on 9 Jan 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses Laurent Dacheux1*, Minerva Cervantes-Gonzalez1,
    [Show full text]
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Hesperetin Protects Crayfish Procambarus Clarkii Against White
    Fish and Shellfish Immunology 93 (2019) 116–123 Contents lists available at ScienceDirect Fish and Shellfish Immunology journal homepage: www.elsevier.com/locate/fsi Full length article Hesperetin protects crayfish Procambarus clarkii against white spot syndrome virus infection T Xiyi Qian, Fei Zhu* Zhejiang Provincial Engineering Laboratory for Animal Health Inspection and Internet Technology, College of Animal Science and Technology, Zhejiang Agriculture and Forestry University, Hangzhou, 311300, China ARTICLE INFO ABSTRACT Keywords: Hesperetin is a natural flavanone compound, which mainly exists in lemons and oranges, and has potential Hesperetin antiviral and anticancer activities. In this study, hesperetin was used in a crayfish pathogen challenge to discover WSSV its effects on the innate immune system of invertebrates. The crayfish Procambarus clarkii was used as an ex- Innate immunity perimental model and challenged with white spot syndrome virus (WSSV). Pathogen challenge experiments Procambarus clarkii showed that hesperetin treatment significantly reduced the mortality caused by WSSV infection, while the VP28 copies of WSSV were also reduced. Quantitative reverse transcriptase polymerase chain reaction revealed that hesperetin increased the expression of several innate immune-related genes, including NF-kappaB and C-type lectin. Further analysis showed that hesperetin treatment plays a positive effects on three immune parameters like total hemocyte count, phenoloxidase and superoxide dismutase activity. Nevertheless, whether or not in- fected with WSSV, hesperetin treatment would significantly increase the hemocyte apoptosis rates in crayfish. These results indicated that hesperetin could regulate the innate immunity of crayfish, and delaying and re- ducing the mortality after WSSV challenge. Therefore, the present study provided novel insights into the po- tential therapeutic or preventive functions associated with hesperetin to regulate crayfish immunity and protect crayfish against WSSV infection, provide certain theoretical basis for production practice.
    [Show full text]
  • Arbovirus Discovery in Central African Republic (1973-1993): Zika, Bozo
    Research Article Annals of Infectious Disease and Epidemiology Published: 13 Nov, 2017 Arbovirus Discovery in Central African Republic (1973- 1993): Zika, Bozo, Bouboui, and More Jean François Saluzzo1, Tom Vincent2, Jay Miller3, Francisco Veas4 and Jean-Paul Gonzalez5* 1Fab’entech, Lyon, France 2O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC, USA 3Department of Infectious Disease, Health Security Partners, Washington, DC, USA 4Laboratoire d’Immunophysiopathologie Moléculaire Comparée-UMR- Ministère de la Défense3, Institute de Recherche pour le Développement, Montpellier, France 5Center of Excellence for Emerging and Zoonotic Animal Disease, Kansas State University, Manhattan, KS, USA Abstract The progressive research on yellow fever and the subsequent emergence of the field of arbovirology in the 1950s gave rise to the continued development of a global arbovirus surveillance network with a specific focus on human pathogenic arboviruses of the tropical zone. Though unknown at the time, some of the arboviruses studies would emerge within the temperate zone decades later (e.g.: West Nile, Zika, Chikungunya). However, initial research by the surveillance network was heavily focused on the discovery, isolation, and characterization of numerous arbovirus species. Global arboviral surveillance has revealed a cryptic circulation of several arboviruses, mainly in wild cycles of the tropical forest. Although there are more than 500 registered arbovirus species, a mere one third has proved to be pathogenic to humans (CDC, 2015). Indeed, most known arboviruses did not initially demonstrate a pathogenicity to humans or other vertebrates, and were considered “orphans” (i.e. without known of vertebrate hosts). As a part of this global surveillance network, the Institut Pasteur International Network has endeavored to understand the role played by arboviruses in the etiology of febrile syndromes of unknown origin as one of its research missions.
    [Show full text]
  • Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site
    JOURNAL OF VIROLOGY, July 1996, p. 4707–4713 Vol. 70, No. 7 0022-538X/96/$04.0010 Copyright q 1996, American Society for Microbiology Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site 1 2 2 1 JUN-PING CHEN, JAMES H. STRAUSS, ELLEN G. STRAUSS, AND TERYL K. FREY * Department of Biology, Georgia State University, Atlanta, Georgia 30303,1 and Division of Biology, California Institute of Technology, Pasadena, California 911252 Received 27 October 1995/Accepted 3 April 1996 The region of the rubella virus nonstructural open reading frame that contains the papain-like cysteine protease domain and its cleavage site was expressed with a Sindbis virus vector. Cys-1151 has previously been shown to be required for the activity of the protease (L. D. Marr, C.-Y. Wang, and T. K. Frey, Virology 198:586–592, 1994). Here we show that His-1272 is also necessary for protease activity, consistent with the active site of the enzyme being composed of a catalytic dyad consisting of Cys-1151 and His-1272. By means of radiochemical amino acid sequencing, the site in the polyprotein cleaved by the nonstructural protease was found to follow Gly-1300 in the sequence Gly-1299–Gly-1300–Gly-1301. Mutagenesis studies demonstrated that change of Gly-1300 to alanine or valine abrogated cleavage. In contrast, Gly-1299 and Gly-1301 could be changed to alanine with retention of cleavage, but a change to valine abrogated cleavage. Coexpression of a construct that contains a cleavage site mutation (to serve as a protease) together with a construct that contains a protease mutation (to serve as a substrate) failed to reveal trans cleavage.
    [Show full text]
  • Validation of the Easyscreen Flavivirus Dengue Alphavirus Detection Kit
    RESEARCH ARTICLE Validation of the easyscreen flavivirus dengue alphavirus detection kit based on 3base amplification technology and its application to the 2016/17 Vanuatu dengue outbreak 1 1 1 2 2 Crystal Garae , Kalkoa Kalo , George Junior Pakoa , Rohan Baker , Phill IsaacsID , 2 Douglas Spencer MillarID * a1111111111 1 Vila Central Hospital, Port Vila, Vanuatu, 2 Genetic Signatures, Sydney, Australia a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 Abstract Background OPEN ACCESS The family flaviviridae and alphaviridae contain a diverse group of pathogens that cause sig- Citation: Garae C, Kalo K, Pakoa GJ, Baker R, nificant morbidity and mortality worldwide. Diagnosis of the virus responsible for disease is Isaacs P, Millar DS (2020) Validation of the easyscreen flavivirus dengue alphavirus detection essential to ensure patients receive appropriate clinical management. Very few real-time kit based on 3base amplification technology and its RT-PCR based assays are able to detect the presence of all members of these families application to the 2016/17 Vanuatu dengue using a single primer and probe set. We have developed a novel chemistry, 3base, which outbreak. PLoS ONE 15(1): e0227550. https://doi. org/10.1371/journal.pone.0227550 simplifies the viral nucleic acids allowing the design of RT-PCR assays capable of pan-fam- ily identification. Editor: Abdallah M. Samy, Faculty of Science, Ain Shams University (ASU), EGYPT Methodology/Principal finding Received: April 11, 2019 Synthetic constructs, viral nucleic acids, intact viral particles and characterised reference Accepted: December 16, 2019 materials were used to determine the specificity and sensitivity of the assays. Synthetic con- Published: January 17, 2020 structs demonstrated the sensitivities of the pan-flavivirus detection component were in the Copyright: © 2020 Garae et al.
    [Show full text]
  • Novel Therapeutics for Epstein–Barr Virus
    molecules Review Novel Therapeutics for Epstein–Barr Virus Graciela Andrei *, Erika Trompet and Robert Snoeck Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium; [email protected] (E.T.); [email protected] (R.S.) * Correspondence: [email protected]; Tel.: +32-16-321-915 Academic Editor: Stefano Aquaro Received: 15 February 2019; Accepted: 4 March 2019; Published: 12 March 2019 Abstract: Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult population. Primary EBV infection usually occurs during childhood and is generally asymptomatic, though the virus can cause infectious mononucleosis in 35–50% of the cases when infection occurs later in life. EBV infects mainly B-cells and epithelial cells, establishing latency in resting memory B-cells and possibly also in epithelial cells. EBV is recognized as an oncogenic virus but in immunocompetent hosts, EBV reactivation is controlled by the immune response preventing transformation in vivo. Under immunosuppression, regardless of the cause, the immune system can lose control of EBV replication, which may result in the appearance of neoplasms. The primary malignancies related to EBV are B-cell lymphomas and nasopharyngeal carcinoma, which reflects the primary cell targets of viral infection in vivo. Although a number of antivirals were proven to inhibit EBV replication in vitro, they had limited success in the clinic and to date no antiviral drug has been approved for the treatment of EBV infections. We review here the antiviral drugs that have been evaluated in the clinic to treat EBV infections and discuss novel molecules with anti-EBV activity under investigation as well as new strategies to treat EBV-related diseases.
    [Show full text]
  • Where Do We Stand After Decades of Studying Human Cytomegalovirus?
    microorganisms Review Where do we Stand after Decades of Studying Human Cytomegalovirus? 1, 2, 1 1 Francesca Gugliesi y, Alessandra Coscia y, Gloria Griffante , Ganna Galitska , Selina Pasquero 1, Camilla Albano 1 and Matteo Biolatti 1,* 1 Laboratory of Pathogenesis of Viral Infections, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy; [email protected] (F.G.); gloria.griff[email protected] (G.G.); [email protected] (G.G.); [email protected] (S.P.); [email protected] (C.A.) 2 Complex Structure Neonatology Unit, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 19 March 2020; Accepted: 5 May 2020; Published: 8 May 2020 Abstract: Human cytomegalovirus (HCMV), a linear double-stranded DNA betaherpesvirus belonging to the family of Herpesviridae, is characterized by widespread seroprevalence, ranging between 56% and 94%, strictly dependent on the socioeconomic background of the country being considered. Typically, HCMV causes asymptomatic infection in the immunocompetent population, while in immunocompromised individuals or when transmitted vertically from the mother to the fetus it leads to systemic disease with severe complications and high mortality rate. Following primary infection, HCMV establishes a state of latency primarily in myeloid cells, from which it can be reactivated by various inflammatory stimuli. Several studies have shown that HCMV, despite being a DNA virus, is highly prone to genetic variability that strongly influences its replication and dissemination rates as well as cellular tropism. In this scenario, the few currently available drugs for the treatment of HCMV infections are characterized by high toxicity, poor oral bioavailability, and emerging resistance.
    [Show full text]
  • Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun*
    Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun* Arboviruses have evolved a number of strategies to Chikungunya virus and in the family Bunyaviridae, sand- survive environmental challenges. This review examines fly fever Naples virus (often referred to as Toscana virus), the factors that may determine arbovirus emergence, pro- sandfly fever Sicilian virus, Crimean-Congo hemorrhagic vides examples of arboviruses that have emerged into new fever virus (CCHFV), Inkoo virus, and Tahyna virus, habitats, reviews the arbovirus situation in western Europe which is widespread throughout Europe. Rift Valley fever in detail, discusses potential arthropod vectors, and attempts to predict the risk for arbovirus emergence in the virus (RVFV) and Nairobi sheep disease virus (NSDV) United Kingdom. We conclude that climate change is prob- could be introduced to Europe from Africa through animal ably the most important requirement for the emergence of transportation. Finally, the family Reoviridae contains a arthropodborne diseases such as dengue fever, yellow variety of animal arbovirus pathogens, including blue- fever, Rift Valley fever, Japanese encephalitis, Crimean- tongue virus and African horse sickness virus, both known Congo hemorrhagic fever, bluetongue, and African horse to be circulating in Europe. This review considers whether sickness in the United Kingdom. While other arboviruses, any of these pathogenic arboviruses are likely to emerge such as West Nile virus, Sindbis virus, Tahyna virus, and and cause disease in the United Kingdom in the foresee- Louping ill virus, apparently circulate in the United able future. Kingdom, they do not appear to present an imminent threat to humans or animals.
    [Show full text]